BG34611A3 - Method for producing derivatives of prostaglandine - Google Patents

Method for producing derivatives of prostaglandine

Info

Publication number
BG34611A3
BG34611A3 BG042307A BG4230779A BG34611A3 BG 34611 A3 BG34611 A3 BG 34611A3 BG 042307 A BG042307 A BG 042307A BG 4230779 A BG4230779 A BG 4230779A BG 34611 A3 BG34611 A3 BG 34611A3
Authority
BG
Bulgaria
Prior art keywords
prostaglandine
producing derivatives
derivatives
producing
formulated
Prior art date
Application number
BG042307A
Other languages
Bulgarian (bg)
English (en)
Inventor
Satoru Enomoto
Kiro Asano
Humio Tamura
Hiromitsu Tanaka
Original Assignee
Kureha Kagaku Kogyo Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Kagaku Kogyo Kabushiki Kaisha filed Critical Kureha Kagaku Kogyo Kabushiki Kaisha
Publication of BG34611A3 publication Critical patent/BG34611A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG042307A 1978-01-31 1979-01-30 Method for producing derivatives of prostaglandine BG34611A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53009652A JPS5850236B2 (ja) 1978-01-31 1978-01-31 プロスタグランジン類↓−ステロイドホルモン結合体

Publications (1)

Publication Number Publication Date
BG34611A3 true BG34611A3 (en) 1983-10-15

Family

ID=11726136

Family Applications (1)

Application Number Title Priority Date Filing Date
BG042307A BG34611A3 (en) 1978-01-31 1979-01-30 Method for producing derivatives of prostaglandine

Country Status (11)

Country Link
JP (1) JPS5850236B2 (ro)
AT (1) AT373268B (ro)
BE (1) BE873380A (ro)
BG (1) BG34611A3 (ro)
DD (1) DD141261A5 (ro)
HU (1) HU182517B (ro)
PL (1) PL127780B1 (ro)
RO (1) RO77375A (ro)
SU (1) SU944502A3 (ro)
YU (1) YU42174B (ro)
ZA (1) ZA79305B (ro)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU190007B (en) * 1982-05-06 1986-08-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for producing new aromatic prostacylin analogues
WO2021220061A2 (en) * 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Also Published As

Publication number Publication date
PL127780B1 (en) 1983-11-30
HU182517B (en) 1984-01-30
DD141261A5 (de) 1980-04-23
ATA7979A (de) 1983-05-15
PL213122A1 (pl) 1979-10-08
YU42174B (en) 1988-06-30
RO77375A (ro) 1981-11-04
JPS5850236B2 (ja) 1983-11-09
YU20879A (en) 1983-01-21
BE873380A (fr) 1979-07-10
SU944502A3 (ru) 1982-07-15
AT373268B (de) 1984-01-10
JPS54103858A (en) 1979-08-15
ZA79305B (en) 1980-01-30

Similar Documents

Publication Publication Date Title
BG34336A3 (bg) Метод за получаване на производни на фталазин -4- ил-оцетна киселина
BG30474A3 (bg) Метод за получаване на 6-п-пропил-8-метоксиметил-или- метилмеркаптометилерголини и сродни съединения
BG31375A3 (bg) Метод за получаване на фенетаноламини
BG34906A3 (bg) Метод за получаване на пиримидони
BG33886A3 (en) Method for heterocyclic compounds producing
BG28061A3 (en) Method of obtaining of hexahydrodibenzopyranones
BG34338A3 (bg) Метод за получаване на тиадиазолилцефалоспорини
BG31945A3 (bg) Метод за получаване на 4-ациламино-фенил-етаноламини
BG33294A3 (bg) Метод за получаване на антитуморни производни на 4-дезацетил vlвс-3 карбоксхидразид
BG32850A3 (en) Method for obtaining of 6 a, 10 a- cis- hexahydrodibenzopyranols
BG36197A3 (bg) Метод за производство на инданилови производни
BG41124A3 (en) Method for preparing benzamides
BG28072A4 (bg) Метод за получаване на 1 n заместени канамицинови производни
BG31070A3 (bg) Метод за получаване на 11-дезокси-16-арил-сигма- тетранорпростагландини
BG38337A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
BG37840A3 (bg) Метод за получаване на производни на ортокондензиран пирол
BG28066A3 (bg) Метод за получаване на пиридобензодиазепинони
BG30925A3 (en) Method for thiocharbamate derivatives obtaining
BG31947A3 (bg) Метод за получаване на ацетидинови производни
BG34456A3 (bg) Метод за получаване на производни на 7 бета- аминотиазолилацетамидо- 3- цефем- 4- карбоновата киселина
BG30926A3 (bg) Метод за получаване на n-(1-метил-2-пиролидинилметил-2,3-диметокси- 5-метилсулфамоилбензамид и негови производни
BG41819A3 (en) Method for preparing 9- hydroxyetoxymethyl guanidine derivative
BG36347A3 (en) Method for preparing thienopyridinon derivatives
BG29284A3 (bg) Метод за получаване на 3-ди-п пропилацетокси бензодиазепин-2-они
BG38640A3 (en) Method for preparing n- arylsulphenyl- n- diaryloxy- phosphinylmethylglycinates